Novel Preclinical Drug Could Have Potential to Combat Depression, Brain Injury, and Cognitive Disorders
FeaturedNeurologyNeuroscienceOpen Neuroscience Articles·November 12, 2019·4 min readPotential vitamin and Alzheimer’s drug produced in yeastResearchers were able to produce 0.6 grams of ergothioneine, a natural amino acid that has promising effects on Alzheimer's disease in animal studies, per liter of yeast broth via a small scale fermentation process.Read More
